Business models for a vaccine manufacturing organisation in Sweden ready to respond quickly in a pandemic situation

Important results from the project

The project has aimed to investigate potential business models for a Swedish industrial-government-academic consortium to meet the need to manufacture vaccines in a pandemic. The project has reached the goal of giving a first picture of what this might look like, the report is attached.

Expected long term effects

The report should be seen as a first tentative survey and gives several recommendations: - There must be political will to act long-term and proactively before the next pandemic. - Establishment of a permanent "pandemic task force" with clear mandates should be explored. - Engage with continuous inventory and mapping of Sweden´s capacity to produce a vaccine - A consortium of actors must include the entire value chain to lower the risk of production shortages. - Sweden is a small country, it will be important to establish cooperation with other nations.

Approach and implementation

The project has been carried out as mainly a student project with two students from Karolinska Institutet. RISE and Cytiva Testa centre have supervised and offered their networks to the students.